Xu, T., Shen, L., Li, J., Deng, Y., Li, H., Yang, W., Liu, Z., Zhang, Y., Wang, Q., Gu, Y., Liang, X., Zong, H., Li, Y., Wang, Z., Jin, Y., Yu, A., Yingyi, J., Huang, C. (2026). SHR-A1811 plus chemotherapy and BP102 as 1L therapy for HER2-expressing mCRC: Data from a phase Ib/II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3569